226 related articles for article (PubMed ID: 32011655)
21. High-throughput electrophysiological assays for voltage gated ion channels using SyncroPatch 768PE.
Li T; Lu G; Chiang EY; Chernov-Rogan T; Grogan JL; Chen J
PLoS One; 2017; 12(7):e0180154. PubMed ID: 28683073
[TBL] [Abstract][Full Text] [Related]
22. Functional profiles of SCN9A variants in dorsal root ganglion neurons and superior cervical ganglion neurons correlate with autonomic symptoms in small fibre neuropathy.
Han C; Hoeijmakers JG; Liu S; Gerrits MM; te Morsche RH; Lauria G; Dib-Hajj SD; Drenth JP; Faber CG; Merkies IS; Waxman SG
Brain; 2012 Sep; 135(Pt 9):2613-28. PubMed ID: 22826602
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.
Wang Y; Mi J; Lu K; Lu Y; Wang K
PLoS One; 2015; 10(6):e0128653. PubMed ID: 26068619
[TBL] [Abstract][Full Text] [Related]
24. Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models.
Xue Y; Chidiac C; Herault Y; Gaveriaux-Ruff C
Neurosci Lett; 2021 May; 753():135844. PubMed ID: 33775738
[TBL] [Abstract][Full Text] [Related]
25. Lacosamide Inhibition of Na
Labau JIR; Alsaloum M; Estacion M; Tanaka B; Dib-Hajj FB; Lauria G; Smeets HJM; Faber CG; Dib-Hajj S; Waxman SG
Front Pharmacol; 2021; 12():791740. PubMed ID: 34992539
[TBL] [Abstract][Full Text] [Related]
26. A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity.
Sheets PL; Jackson JO; Waxman SG; Dib-Hajj SD; Cummins TR
J Physiol; 2007 Jun; 581(Pt 3):1019-31. PubMed ID: 17430993
[TBL] [Abstract][Full Text] [Related]
27. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M
Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399
[TBL] [Abstract][Full Text] [Related]
28. Assessing the impact of pain-linked Nav1.7 variants: An example of two variants with no biophysical effect.
Le Cann K; Meents JE; Sudha Bhagavath Eswaran V; Dohrn MF; Bott R; Maier A; Bialer M; Hautvast P; Erickson A; Rolke R; Rothermel M; Körner J; Kurth I; Lampert A
Channels (Austin); 2021 Dec; 15(1):208-228. PubMed ID: 33487118
[TBL] [Abstract][Full Text] [Related]
29. Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy.
Blesneac I; Themistocleous AC; Fratter C; Conrad LJ; Ramirez JD; Cox JJ; Tesfaye S; Shillo PR; Rice ASC; Tucker SJ; Bennett DLH
Pain; 2018 Mar; 159(3):469-480. PubMed ID: 29176367
[TBL] [Abstract][Full Text] [Related]
30. Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia.
Cregg R; Laguda B; Werdehausen R; Cox JJ; Linley JE; Ramirez JD; Bodi I; Markiewicz M; Howell KJ; Chen YC; Agnew K; Houlden H; Lunn MP; Bennett DL; Wood JN; Kinali M
Neuromolecular Med; 2013 Jun; 15(2):265-78. PubMed ID: 23292638
[TBL] [Abstract][Full Text] [Related]
31. Antidepressants inhibit Na
Horishita T; Yanagihara N; Ueno S; Okura D; Horishita R; Minami T; Ogata Y; Sudo Y; Uezono Y; Sata T; Kawasaki T
Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1255-1270. PubMed ID: 28905186
[TBL] [Abstract][Full Text] [Related]
32. Atypical changes in DRG neuron excitability and complex pain phenotype associated with a Na
Huang J; Mis MA; Tanaka B; Adi T; Estacion M; Liu S; Walker S; Dib-Hajj SD; Waxman SG
Sci Rep; 2018 Jan; 8(1):1811. PubMed ID: 29379075
[TBL] [Abstract][Full Text] [Related]
33. Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel Na
Kornecook TJ; Yin R; Altmann S; Be X; Berry V; Ilch CP; Jarosh M; Johnson D; Lee JH; Lehto SG; Ligutti J; Liu D; Luther J; Matson D; Ortuno D; Roberts J; Taborn K; Wang J; Weiss MM; Yu V; Zhu DXD; Fremeau RT; Moyer BD
J Pharmacol Exp Ther; 2017 Jul; 362(1):146-160. PubMed ID: 28473457
[TBL] [Abstract][Full Text] [Related]
34. [Pain and analgesia : Mutations of voltage-gated sodium channels].
Eberhardt MJ; Leffler A
Schmerz; 2017 Feb; 31(1):14-22. PubMed ID: 27402262
[TBL] [Abstract][Full Text] [Related]
35. Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors.
Shields SD; Deng L; Reese RM; Dourado M; Tao J; Foreman O; Chang JH; Hackos DH
J Neurosci; 2018 Nov; 38(47):10180-10201. PubMed ID: 30301756
[TBL] [Abstract][Full Text] [Related]
36. Network topology of NaV1.7 mutations in sodium channel-related painful disorders.
Kapetis D; Sassone J; Yang Y; Galbardi B; Xenakis MN; Westra RL; Szklarczyk R; Lindsey P; Faber CG; Gerrits M; Merkies IS; Dib-Hajj SD; Mantegazza M; Waxman SG; Lauria G;
BMC Syst Biol; 2017 Feb; 11(1):28. PubMed ID: 28235406
[TBL] [Abstract][Full Text] [Related]
37. Oxidation differentially modulates the recombinant voltage-gated Na(+) channel α-subunits Nav1.7 and Nav1.8.
Schlüter F; Leffler A
Brain Res; 2016 Oct; 1648(Pt A):127-135. PubMed ID: 27450927
[TBL] [Abstract][Full Text] [Related]
38. Increased Resurgent Sodium Currents in Nav1.8 Contribute to Nociceptive Sensory Neuron Hyperexcitability Associated with Peripheral Neuropathies.
Xiao Y; Barbosa C; Pei Z; Xie W; Strong JA; Zhang JM; Cummins TR
J Neurosci; 2019 Feb; 39(8):1539-1550. PubMed ID: 30617209
[TBL] [Abstract][Full Text] [Related]
39. Gain-of-function mutation of a voltage-gated sodium channel Na
Tanaka BS; Nguyen PT; Zhou EY; Yang Y; Yarov-Yarovoy V; Dib-Hajj SD; Waxman SG
J Biol Chem; 2017 Jun; 292(22):9262-9272. PubMed ID: 28381558
[TBL] [Abstract][Full Text] [Related]
40. Two independent mouse lines carrying the Nav1.7 I228M gain-of-function variant display dorsal root ganglion neuron hyperexcitability but a minimal pain phenotype.
Chen L; Wimalasena NK; Shim J; Han C; Lee SI; Gonzalez-Cano R; Estacion M; Faber CG; Lauria G; Dib-Hajj SD; Woolf CJ; Waxman SG
Pain; 2021 Jun; 162(6):1758-1770. PubMed ID: 33323889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
